Abstract
Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.
| Original language | English |
|---|---|
| Pages (from-to) | 2293-2294 |
| Number of pages | 2 |
| Journal | Clinical Case Reports |
| Volume | 8 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2020 |
Keywords
- ALL
- CSF xanthochromia
- hepatotoxicity
- pegasparaginase
Fingerprint
Dive into the research topics of 'Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver